118 related articles for article (PubMed ID: 6157489)
1. Spontaneous cytotoxicity mediated by human monocyte-macrophages against human fibroblasts infected with herpes simplex virsu--augmentation by interferon.
Stanwick TL; Campbell DE; Nahmias AJ
Cell Immunol; 1980 Aug; 53(2):413-6. PubMed ID: 6157489
[No Abstract] [Full Text] [Related]
2. Cytotoxic properties of human monocyte-macrophages for human fibroblasts infected in herpes simplex virus: interferon production and augmentation.
Stanwick TL; Campbell DE; Nahmias AJ
Cell Immunol; 1982 Jun; 70(1):132-47. PubMed ID: 6180837
[No Abstract] [Full Text] [Related]
3. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
Kohl S; Loo LS; Greenberg SB
J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
[No Abstract] [Full Text] [Related]
4. Human colostral cytotoxicity: I. Antibody-dependent cellular cytotoxicity against Herpes simplex viral-infected cells mediated by colostral cells.
Kohl S; Malloy MM; Pickering LK; Morriss FH; Adcock EW; Walters DL
J Clin Lab Immunol; 1978 Nov; 1(3):221-4. PubMed ID: 756470
[TBL] [Abstract][Full Text] [Related]
5. Cells infected with herpes simplex virus induce human monocyte-macrophages to produce interferon.
Stanwick TL; Campbell DE; Nahmias AJ
Immunobiology; 1981; 158(3):207-12. PubMed ID: 6163697
[TBL] [Abstract][Full Text] [Related]
6. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex.
Kohl S; Shaban SS; Starr SE; Wood PA; Nahmias AJ
J Pediatr; 1978 Aug; 93(2):206-10. PubMed ID: 671153
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human monocyte-macrophage and lymphocyte cytotoxicity to herpes simplex-infected cells by glucan.
Kohl S; Pickering LK; Diluzio NR
J Immunol Methods; 1979; 29(4):361-8. PubMed ID: 229165
[TBL] [Abstract][Full Text] [Related]
8. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human cells with prostaglandins and cyclic AMP modulators. I. Effects on complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts.
Trofatter KF; Daniels CA
J Immunol; 1979 Apr; 122(4):1363-70. PubMed ID: 221573
[No Abstract] [Full Text] [Related]
10. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
11. Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.
Kohl S; Moore CM
Immunology; 1983 Jan; 48(1):187-93. PubMed ID: 6848451
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
[TBL] [Abstract][Full Text] [Related]
14. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
Gonik B; Loo LS; Bigelow R; Kohl S
J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
[TBL] [Abstract][Full Text] [Related]
15. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
Kohl S; Loo LS; Schmalstieg FS; Anderson DC
J Immunol; 1986 Sep; 137(5):1688-94. PubMed ID: 3528287
[TBL] [Abstract][Full Text] [Related]
16. Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.
Herberman RB; Ortaldo JR; Mantovani A; Hobbs DS; Kung HF; Pestka S
Cell Immunol; 1982 Feb; 67(1):160-7. PubMed ID: 6176335
[No Abstract] [Full Text] [Related]
17. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
Santoli D; Trinchieri G; Koprowski H
J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism.
Kohl S; Loo LS; Drath DB; Cox P
J Infect Dis; 1989 Feb; 159(2):239-47. PubMed ID: 2492588
[TBL] [Abstract][Full Text] [Related]
20. Activity of rabbit monocytes, macrophages, and neutrophils in antibody-dependent cellular cytotoxicity of herpes simplex virus-infected corneal cells.
Smith JW; Sheppard AM
Infect Immun; 1982 May; 36(2):685-90. PubMed ID: 6282757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
